Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 2];10(2):s740. Available from: https://skin.dermsquared.com/skin/article/view/4098